COMMUNIQUÉS West-GlobeNewswire

Medtronic Foundation Recognizes 12 Bakken Invitation Honorees for Driving Positive Change in Healthcare
09/01/2019
Program Celebrates the Legacy of Medtronic Co-Founder Earl Bakken and Other Outstanding Patient Advocates Around the World MINNEAPOLIS and Kona, Hawaii - January 9, 2019 - The Medtronic Foundation today announced 12 [...]
Results-Based Outsourcing Inc., Announces Name Change to Driven Inc.
09/01/2019
Company provides update on Capitalization Structure SAN DIEGO, Jan. 09, 2019 (GLOBE NEWSWIRE) -- Results Based Outsourcing Inc. (RBOS) today announced that it has received approval for plans to change the corporate name [...]
Intuitive Surgical Announces Preliminary Fourth Quarter and Full Year 2018 Results
09/01/2019
SUNNYVALE, Calif., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Intuitive Surgical, Inc. (“Intuitive”) (Nasdaq: ISRG), the pioneer and a global technology leader in robotic-assisted, minimally invasive surgery, today announced [...]
Dr. Jeffrey D. Gross of Newport Beach, CA Now Offering Free Virtual Second Opinion Consultations for Surgery
09/01/2019
NEWPORT BEACH, Calif., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Dr. Jeffrey D. Gross, a board-certified neurological surgeon, today announced he is now offering comprehensive second opinion consultations for patients [...]
UPDATE -- Moving forward with Cannabis Sales License, Abba Medix Eyes EU-GMP Certification, Signs Agreement with Cannabis OneFive, Inc.
09/01/2019
TORONTO, Jan. 09, 2019 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (“Canada House” or the “Company”) (CSE:CHV) through its wholly owned subsidiary Abba Medix Corp. (“Abba”) has initiated the process for its [...]
Two Marrone Bio Innovations products, MBI-110 Biofungicide and Haven Sunprotectant, approved for sale in Canada
09/01/2019
DAVIS, Calif., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Marrone Bio Innovations Inc. (NASDAQ: MBII) (MBI), an international leader in smart biopesticide and plant health solutions, today announced that two of its products have [...]
Sharps Compliance Announces Second Quarter Fiscal 2019 Conference Call and Webcast
09/01/2019
HOUSTON, Jan. 09, 2019 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (Nasdaq: SMED) announced today that it will release its second quarter 2019 results for the period ended December 31, 2018, before the opening of the [...]
Wildflower Experience Shop-in-Shop Retail Launches in New York City
09/01/2019
VANCOUVER, British Columbia, Jan. 09, 2019 (GLOBE NEWSWIRE) -- Wildflower Brands Inc. (CSE: SUN , OTC: WLDFF ) (the “ Company ”), is excited to announce the opening of our first shop-in-shop partnership with Retail Worx [...]
Exclusive Interview: Lexaria CEO Discusses Progress & Plans at O’Cannabiz 2018 -- CFN Media
09/01/2019
SEATTLE, Jan. 09, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
OncBioMune Announces Former Puma Biotechnology Executive and Genentech Veteran Brian Barnett, M.D., as Chief Executive Officer
09/01/2019
BATON ROUGE, La., Jan. 09, 2019 (GLOBE NEWSWIRE) -- OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a clinical-stage biopharmaceutical company engaged in the development of a proprietary [...]
Moving forward with Cannabis Sales License, Abba Medix Eyes EU-GMP Certification, Signs Agreement with Cannabis OneFive, Inc.
09/01/2019
TORONTO, Jan. 09, 2019 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (“Canada House” or the “Company”) (CSE:CHV) through its wholly owned subsidiary Abba Medix Corp. (“Abba”) has initiated the process for its [...]
Southeastern Grocers Partner with eTrueNorth to Launch CLIA-waived Laboratory for Point-of-Care Testing at Local Pharmacies
09/01/2019
BI-LO, Fresco y Más, Harveys Supermarket and Winn-Dixie pharmacies will accept eLabNetwork® vouchers and provide onsite wellness screenings FORT WORTH, Texas, Jan. 09, 2019 (GLOBE NEWSWIRE) -- e TrueNorth, the premier, [...]
Acasti Pharma Awarded Broad Composition-of-Matter and Method of Use Patents by the European Patent Office
09/01/2019
LAVAL, Québec, Jan. 09, 2019 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of [...]
CareDx to Present New AlloSure® Data at American Society of Transplant Surgeons Winter Symposium
09/01/2019
AlloSure utility studied in patients with delayed graft function BRISBANE, Calif., Jan. 09, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the discovery, development and [...]
Pluristem Therapeutics Reports Successful Case Study in Treatment of Buerger’s Disease Patient
09/01/2019
Buerger’s disease is a severe vascular inflammatory disease associated with high risk of amputation Patient was at a pre-amputation stage and was treated with PLX-PAD cell therapy under compassionate use treatment After [...]
Cancer Genetics Strengthens Management Team with Appointment of William Finger as Executive Vice President, Precision Medicine and Pharma Services
09/01/2019
Executive appointment underscores continued execution of new corporate strategy of expanding Biopharma and Discovery businesses RUTHERFORD, N.J. and RESEARCH TRIANGLE PARK, N.C., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Cancer [...]
Verona Pharma Receives WHO Approval for “ensifentrine” as Recommended INN for RPL554
09/01/2019
Assignment of the “-fentrine” stem in the INN attests to RPL554’s dual phosphodiesterase inhibitor mechanism of action LONDON, Jan. 09, 2019 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) (“Verona Pharma [...]
Rafael Pharmaceuticals Announces Initiation of Phase II Trial of CPI-613 in Combination with Modified FOLFIRINOX in Locally Advanced Pancreatic Cancer
09/01/2019
Newark, NJ, Jan. 09, 2019 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc., a leader in the growing field of cancer metabolism-based therapeutics, today announced the initiation of a phase II open-label trial in [...]
Akorn Receives FDA Warning Letter
09/01/2019
LAKE FOREST, Ill., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, announced that it received a warning letter, dated January 4, from the U.S. Food and [...]

Pages